Agenus
AGEN
#8311
Rank
NZ$0.57 B
Marketcap
NZ$12.70
Share price
0.00%
Change (1 day)
69.70%
Change (1 year)

Earnings for Agenus (AGEN)

Earnings in 2026 (TTM): NZ$0.26 Billion

According to Agenus 's latest financial reports the company's current earnings are NZ$0.13 Billion. In 2025 the company made an earning of NZ$92.67 Million, an increase over its 2024 earnings that were of -NZ$0.21 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Agenus from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.26 B182.48%
2025 NZ$92.67 M-145.52%
2024 -NZ$0.21 Billion-28.13%
2023 -NZ$0.29 Billion-5.5%
2022 -NZ$0.3 Billion-556.26%
2021 NZ$65.69 M-130.37%
2020 -NZ$0.22 Billion73.75%
2019 -NZ$0.13 Billion-48.74%
2018 -NZ$0.25 Billion34.32%
2017 -NZ$0.19 Billion-7.16%
2016 -NZ$0.2 Billion26.55%
2015 -NZ$0.16 Billion110.24%
2014 -NZ$73.21 Million49.12%
2013 -NZ$49.09 Million
2011 -NZ$33.9 Million-12.25%
2010 -NZ$38.63 Million-21.41%
2009 -NZ$49.15 Million-26.86%
2008 -NZ$67.2 Million13.72%
2007 -NZ$59.1 Million-33.4%
2006 -NZ$88.73 Million-31.84%
2005 -NZ$0.14 Billion9.74%
2004 -NZ$0.12 Billion-0.8%
2003 -NZ$0.12 Billion17.37%
2002 -NZ$0.11 Billion37.83%
2001 -NZ$73.92 Million55.99%
2000 -NZ$47.39 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$33.24 B 12,294.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$13.65 B 4,991.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$20.12 B 7,402.75%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$12.70 B 4,636.87%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-NZ$0.58 Billion-315.73%๐Ÿ‡บ๐Ÿ‡ธ USA